Literature DB >> 26041566

ALFF Value in Right Parahippocampal Gyrus Acts as a Potential Marker Monitoring Amyotrophic Lateral Sclerosis Progression: a Neuropsychological, Voxel-Based Morphometry, and Resting-State Functional MRI Study.

Wenjia Zhu1, Xiaoling Fu, Fang Cui, Fei Yang, Yuting Ren, Xiaoyun Zhang, Xiaolan Zhang, Zhaohui Chen, Li Ling, Xusheng Huang.   

Abstract

The aim of this study is to analyze cognitive impairment in amyotrophic lateral sclerosis (ALS). Forty-four participants matched for age, sex, and educational background were enrolled as the sporadic ALS group (n = 22) and the control group (n = 22). All participants completed comprehensive neuropsychological tests, including the Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), the Stroop Color-Word Interference Test (SCWT), the Wisconsin Card Sorting Test (WCST), and the Frontal Assessment Battery. The participants underwent a series of 3.0 Tesla magnetic resonance imaging (MRI) scans. Resting-state functional MRI (Rs-fMRI) using the amplitude of low-frequency fluctuation (ALFF) was performed. Three-dimensional T1-weighted anatomical images obtained by voxel-based morphometry (VBM) were used to conduct correlation analyses and group comparisons with the demographic and neuropsychological characteristics. The results indicated that the decreased gray matter (GM) volume in the bilateral precentral gyri and increased ALFF values in the right parahippocampal gyrus, left inferior temporal gyrus, left anterior cingulate gyrus, right superior frontal gyrus, and left middle occipital gyrus were identified in the sporadic ALS group. The increased ALFF value in the right parahippocampal gyrus was positively correlated with ALS progression rate. The ALS patients exhibited poor performances on cognitive and executive tests, which were significantly or marginally significantly correlated with the ALFF values in the anterior cingulate gyrus and the frontal, temporal, and parahippocampal cortices. In conclusion, these findings provide evidence of an extramotor involvement and suggest that the ALFF value in the right parahippocampal gyrus could represent a potential marker to monitor disease progression.

Entities:  

Mesh:

Year:  2015        PMID: 26041566     DOI: 10.1007/s12031-015-0583-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  34 in total

1.  Cognitive function in patients with late stage amyotrophic lateral sclerosis.

Authors:  J Lakerveld; B Kotchoubey; A Kübler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-22       Impact factor: 10.154

Review 2.  Presymptomatic studies in ALS: rationale, challenges, and approach.

Authors:  Michael Benatar; Joanne Wuu
Journal:  Neurology       Date:  2012-10-16       Impact factor: 9.910

3.  Edinburgh Handedness Inventory - Short Form: a revised version based on confirmatory factor analysis.

Authors:  Jaimie F Veale
Journal:  Laterality       Date:  2013-05-10

Review 4.  The frontotemporal syndromes of ALS. Clinicopathological correlates.

Authors:  Michael Joseph Strong; Wencheng Yang
Journal:  J Mol Neurosci       Date:  2011-08-02       Impact factor: 3.444

Review 5.  The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunction.

Authors:  Stella Tsermentseli; P Nigel Leigh; Laura H Goldstein
Journal:  Cortex       Date:  2011-02-12       Impact factor: 4.027

Review 6.  Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.

Authors:  Heiko Braak; Johannes Brettschneider; Albert C Ludolph; Virginia M Lee; John Q Trojanowski; Kelly Del Tredici
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

7.  Cognitive changes predict functional decline in ALS: a population-based longitudinal study.

Authors:  Marwa Elamin; Peter Bede; Susan Byrne; Norah Jordan; Laura Gallagher; Brona Wynne; Caoimhe O'Brien; Julie Phukan; Catherine Lynch; Niall Pender; Orla Hardiman
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

8.  Microstructural white matter correlates of emotion recognition impairment in Amyotrophic Lateral Sclerosis.

Authors:  Chiara Crespi; Chiara Cerami; Alessandra Dodich; Nicola Canessa; Marta Arpone; Sandro Iannaccone; Massimo Corbo; Christian Lunetta; Elisa Scola; Andrea Falini; Stefano F Cappa
Journal:  Cortex       Date:  2014-01-18       Impact factor: 4.027

9.  Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Bradley F Boeve; Matthew L Senjem; Jeffrey L Gunter; Mariely DeJesus-Hernandez; Nicola J Rutherford; Matthew Baker; David S Knopman; Zbigniew K Wszolek; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

Review 10.  Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.

Authors:  Jacqueline Ann Nicholas; Aaron Lee Boster; Jaime Imitola; Colleen O'Connell; Michael Karl Racke
Journal:  Drug Des Devel Ther       Date:  2014-07-07       Impact factor: 4.162

View more
  5 in total

1.  Spontaneous brain activity in the sensorimotor cortex in amyotrophic lateral sclerosis can be negatively regulated by corticospinal fiber integrity.

Authors:  Wataru Sako; Takashi Abe; Yuishin Izumi; Hiroki Yamazaki; Naoko Matsui; Masafumi Harada; Ryuji Kaji
Journal:  Neurol Sci       Date:  2017-02-01       Impact factor: 3.307

2.  Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis.

Authors:  Weina Li; Jiuquan Zhang; Chaoyang Zhou; Wensheng Hou; Jun Hu; Hua Feng; Xiaolin Zheng
Journal:  Front Aging Neurosci       Date:  2018-07-17       Impact factor: 5.750

Review 3.  Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis.

Authors:  Miguel Mazón; Juan Francisco Vázquez Costa; Amadeo Ten-Esteve; Luis Martí-Bonmatí
Journal:  Front Neurosci       Date:  2018-10-25       Impact factor: 4.677

Review 4.  The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review.

Authors:  G Grolez; C Moreau; V Danel-Brunaud; C Delmaire; R Lopes; P F Pradat; M M El Mendili; L Defebvre; D Devos
Journal:  BMC Neurol       Date:  2016-08-27       Impact factor: 2.474

Review 5.  The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis.

Authors:  Foteini Christidi; Efstratios Karavasilis; Georgios Velonakis; Panagiotis Ferentinos; Michail Rentzos; Nikolaos Kelekis; Ioannis Evdokimidis; Peter Bede
Journal:  Front Neurol       Date:  2018-07-03       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.